Seattle Ranks 10th in Top 10 US Biopharma Clusters

Seattle and the greater Puget Sound rank eighth in NIH funding (2,486 awards totaling $1.842B) and venture capital ($854.5M in 2023 and $334M in Q1–Q2 2024, according to statewide industry group Life Science Washington). The region ranks ninth in lab space (8.5M square feet, according to JLL data cited by Life Science Washington), and 10th in both patents (4,783 families) and jobs – 46,540 according to Life Science Washington’s Economic Impact Report released in April but based on 2022 data.